Monday, September 28, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 25, 2026

Stellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research

View original at globenewswire.com
Stellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research Prague, Czechia, May 25, 2026 (GLOBE NEWSWIRE) -- Stellora.AI, a deep-tech artificial intelligence startup developing advanced agentic AI and quantum workflow technology, today announced the continued advancement of Stellora.A…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stellora.AI is opening demo access because it wants serious partners to experience where the technology is going and how it can support meaningful scientific progress.

    60% confidence
  • Quantum Flow is not intended to replace researchers, doctors, or pharmaceutical laboratories, but is being developed as a powerful workflow assistant for scientific teams.

    60% confidence
  • Quantum Flow is designed to generate functional quantum circuits and quantum code tailored to specific research goals, working with scientific studies, quantum theories, target machine SDK documentation, and target quantum machine requirements.

    60% confidence
  • With Quantum Flow, Stellora.AI is building a bridge between validated research, quantum SDKs, and functional quantum circuits so researchers can move faster from idea to experimentation.

    60% confidence
  • Stellora.AI sees Quantum Flow as applicable for biomedical discovery, computational chemistry, precision medicine, and disease research where complex modeling and simulation are essential.

    60% confidence
  • Every improvement in Quantum Flow brings Stellora.AI closer to a future where AI can help scientists generate, test, and refine quantum workflows for healthcare, drug discovery, and disease research, with the goal of empowering researchers rather than replacing them.

    60% confidence
  • Stellora.AI was never created to be just another AI tool. Our mission is to help humanity by making advanced, trusted intelligence available for the most important scientific challenges.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com